Zobrazeno 1 - 7
of 7
pro vyhledávání: '"T J, Perren"'
Publikováno v:
British Journal of Cancer
The treatment of metastatic or advanced breast cancer has evolved over the last few years, and in the 1990s this was largely due to the introduction of the taxane family of drugs. Docetaxel (taxotere) is a semisynthetic taxane derived from 10-deacety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e598ff314110f685a7fb7db6b1c9b6f4
http://europepmc.org/articles/PMC2409488
http://europepmc.org/articles/PMC2409488
Publikováno v:
International Journal of Gynecologic Cancer. 16:108-110
When women with a history of breast cancer present with peritoneal carcinomatosis, the differential diagnosis lies between recurrent breast cancer or a new primary tumor. This scenario is of particular relevance to women with a BRCA gene mutation, wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07f003a85f712f97111e94106de307d3
https://doi.org/10.1136/ijgc-00009577-200602001-00017
https://doi.org/10.1136/ijgc-00009577-200602001-00017
Autor:
J M, Del Campo, A, Roszak, M, Bidzinski, T E, Ciuleanu, T, Hogberg, M Z, Wojtukiewicz, A, Poveda, K, Boman, A M, Westermann, C, Lebedinsky, T J, Perren
Publikováno v:
Annals of oncology, 20(11), 1794-1802. Oxford University Press
This randomized, open-label, phase II clinical trial evaluated the optimal regimen of trabectedin administered every 3 weeks in patients with platinum-sensitive, relapsed, advanced ovarian cancer (AOC). Patients previously treated with less than two
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4fa79b67a47307098e930339da9e9e2
https://pubmed.ncbi.nlm.nih.gov/19556318
https://pubmed.ncbi.nlm.nih.gov/19556318
Autor:
F E, Davies, A C, Rawstron, G, Pratt, R, Coupe, D, Clarke, A, Lubenko, K, Short, T J, Perren, P J, Selby, S, Maclennan, K, Major, V, Woodhead, F, Robinson, J A, Child, G M, Smith, P W, Johnson, G J, Morgan
Publikováno v:
Hematological oncology. 18(3)
Peripheral blood progenitor cells used during high dose treatments for malignancy may be contaminated with tumour cells that could later contribute to recurrence. CD34+ selected harvests still contain tumour cells and an additional negative selection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9f21d189e7a25b211552847226453cc9
https://pubmed.ncbi.nlm.nih.gov/11027980
https://pubmed.ncbi.nlm.nih.gov/11027980
Publikováno v:
International journal of cancer. 79(3)
The staging of colorectal cancer currently depends on pathological examination of the surgical specimen and regional lymph nodes, accompanied by imaging tests such as computed tomography (CT) scanning. However, alternative molecular methods to detect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b0abf0e540ccc1c7e641ebe6888311e7
https://pubmed.ncbi.nlm.nih.gov/9645353
https://pubmed.ncbi.nlm.nih.gov/9645353
Autor:
T J, Perren, E, Wiltshaw, P, Harper, M, Slevin, R, Stein, S, Tan, M, Gore, I J, Fryatt, P R, Blake
Publikováno v:
British Journal of Cancer
In a study designed to compare response rates of patients with stage III epithelial ovarian carcinoma to ifosfamide and carboplatin, 152 patients were randomised to receive either sequential therapy with three cycles of ifosfamide followed by three c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bb8c0e1ca95252a570d39a1e951c7e55
https://pubmed.ncbi.nlm.nih.gov/8260372
https://pubmed.ncbi.nlm.nih.gov/8260372
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.